These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 17161727)
1. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Moss SM; Cuckle H; Evans A; Johns L; Waller M; Bobrow L; Lancet; 2006 Dec; 368(9552):2053-60. PubMed ID: 17161727 [TBL] [Abstract][Full Text] [Related]
2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657 [TBL] [Abstract][Full Text] [Related]
3. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144 [TBL] [Abstract][Full Text] [Related]
4. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099 [TBL] [Abstract][Full Text] [Related]
5. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group. Moss S J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845 [TBL] [Abstract][Full Text] [Related]
6. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907 [TBL] [Abstract][Full Text] [Related]
8. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501 [TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance. Johns LE; Moss SM; J Med Screen; 2010; 17(1):37-43. PubMed ID: 20356944 [TBL] [Abstract][Full Text] [Related]
10. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial. Frisell J; Lidbrink E; Hellström L; Rutqvist LE Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892 [TBL] [Abstract][Full Text] [Related]
12. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897 [TBL] [Abstract][Full Text] [Related]
14. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet; 1999 Jun; 353(9168):1909-14. PubMed ID: 10371568 [TBL] [Abstract][Full Text] [Related]
15. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Alexander FE; Anderson TJ; Brown HK; Forrest AP; Hepburn W; Kirkpatrick AE; Muir BB; Prescott RJ; Smith A Lancet; 1999 Jun; 353(9168):1903-8. PubMed ID: 10371567 [TBL] [Abstract][Full Text] [Related]
16. Screening for breast cancer with mammography. Gøtzsche PC; Nielsen M Cochrane Database Syst Rev; 2011 Jan; (1):CD001877. PubMed ID: 21249649 [TBL] [Abstract][Full Text] [Related]
17. Screening for breast cancer with mammography. Gøtzsche PC; Nielsen M Cochrane Database Syst Rev; 2009 Oct; (4):CD001877. PubMed ID: 19821284 [TBL] [Abstract][Full Text] [Related]
18. Screening for breast cancer with mammography. Gøtzsche PC; Nielsen M Cochrane Database Syst Rev; 2006 Oct; (4):CD001877. PubMed ID: 17054145 [TBL] [Abstract][Full Text] [Related]
19. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. FH01 collaborative teams Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374 [TBL] [Abstract][Full Text] [Related]
20. Benefits and Harms of Breast Cancer Screening: A Systematic Review. Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]